Yuta Sawada

Yuta Sawada

Auto-generated profile, based on publicly available information

Yuta Sawada

Department of Orthopaedics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2023 in The Spine Journal
Verified
Journal Article
Closed access
HTHiromitsu Toyoda
Hiromitsu Toyoda
HTHidetomi Terai
Hidetomi Terai
KYKentaro Yamada
Kentaro Yamada
MKMinori Kato
Minori Kato
Akinobu SuzukiAkinobu Suzuki
Akinobu Suzuki
HNHiroaki Nakamura
Hiroaki Nakamura

18 December 2024 in The Spine Journal
Verified
Journal Article
Closed access
YSYuta Sawada
Yuta Sawada
STShinji Takahashi
Shinji Takahashi
HYHiroyuki Yasuda
Hiroyuki Yasuda
MTMasaki Terakawa
Masaki Terakawa
SKSadahiko Konishi
Sadahiko Konishi
HTHidetomi Terai
Hidetomi Terai

29 February 2024 in Asian Spine Journal
Verified
Journal Article
Open access
PDF file
YSYuta Sawada
Yuta Sawada
STShinji Takahashi
Shinji Takahashi
HTHidetomi Terai
Hidetomi Terai
MKMinori Kato
Minori Kato
HTHiromitsu Toyoda
Hiromitsu Toyoda
HNHiroaki Nakamura
Hiroaki Nakamura
Study Design: Level 3 retrospective cohort case-control study.Purpose: This study aimed to investigate the risk factors for distal junctional kyphosis (DJK) caused by osteoporotic vertebral fractures following spinal reconstruction surgery, with a focus on the sagittal stable vertebra.Overview of Literature: Despite the rarity of reports on DJK in this setting, DJK was reported to reduce when the lower instrumented vertebra (LIV) was extended to the sagittal stable vertebra in the posterior corrective fixation for Scheuermann’s disease.Methods: This study included 46 patients who underwent spinal reconstruction surgery for thoracolumbar osteoporotic vertebral fractures and kyphosis and were followed up for 1 year postoperatively. DJK was defined as an advanced kyphosis angle >10° between the LIV and one lower vertebra. The patients were divided into groups with and without DJK. The risk factors of the two groups, such as patient background, surgery-related factors, radiographic parameters, and clinical outcomes, were analyzed.Results: The DJK and non-DJK groups included 14 and 32 patients, respectively, without significant differences in patient background. Those with instability in the distal adjacent LIV disc had a significantly higher risk of DJK occurrence (28.6% vs. 3.2%, p=0.027). DJK occurrence significantly increased in those with the sagittal stable vertebra not included in the fixation range (57.1% vs. 18.8%, p=0.020). Other preoperative radiographic parameters were not significantly different. Instability in the distal adjacent LIV disc (adjusted odds ratio, 14.50; p=0.029) and the exclusion of the sagittal stable vertebra from the fixation range (adjusted odds ratio, 5.29; p=0.020) were significant risk factors for DJK occurrence.Conclusions: Regarding spinal reconstruction surgery in patients with osteoporotic vertebral fractures, instability in the distal adjacent LIV disc and the exclusion of the sagittal stable vertebra from the fixation range were risk factors for DJK occurrence in the short term.

29 January 2025 in Global Spine Journal
Verified
Journal Article
Open access
YSYuta Sawada
Yuta Sawada
KTKoji Tamai
Koji Tamai
HTHiromitsu Toyoda
Hiromitsu Toyoda
MKMinori Kato
Minori Kato
ASAkinobu Suzuki
Akinobu Suzuki
HTHidetomi Terai
Hidetomi Terai
Study Design: Retrospective cohort study. Objectives: Spinal surgeons face a dilemma regarding the continuation or discontinuation of antiplatelet agents during the perioperative period. Guidelines recommend considering the balance between thrombotic and bleeding risks. However, no consensus exists for the use of these agents for patients who undergo minimally invasive lumbar decompression. This study aimed to assess the effect of continued antiplatelet medication on minimally invasive posterior lumbar decompression surgery outcomes, focusing on perioperative outcomes and 1-year postoperative clinical results. Methods: This study included 106 patients who underwent minimally invasive posterior lumbar decompression between 2017 and 2022 and were taking antiplatelet medications before spinal surgery. Patient characteristics, antiplatelet medication type, and perioperative data were analyzed. Patients were divided into “continuation” and “discontinuation” groups based on preoperative antiplatelet medication status. Univariate and multivariate linear regression analyses were performed. Results: No significant differences were observed between groups in terms of surgical time, intraoperative blood loss, postoperative drain volume, complication rates, and Japanese Orthopedic Association scores and EuroQoL-5 dimensions 5-level at 1 year postoperatively. Similar results were noted in groups focusing exclusively on patients treated with aspirin. Multivariate linear regression revealed that surgical time per level was significantly associated with total blood loss, whereas antiplatelet medications did not show a significant relationship (operative time per level, P < 0.01; antiplatelet drugs, P = 0.459). Conclusions: This study suggests that minimally invasive posterior lumbar spine decompression can be performed safely and effectively under continuous antiplatelet medication. Further studies with more evidence are required to validate our findings.

31 October 2026 in Asian Spine Journal
Verified
Journal Article
Open access
PDF file
YKYuki Kinoshita
Yuki Kinoshita
STShinji Takahashi
Shinji Takahashi
HYHiroyuki Yasuda
Hiroyuki Yasuda
MTMasaki Terakawa
Masaki Terakawa
SKSadahiko Konishi
Sadahiko Konishi
HTHidetomi Terai
Hidetomi Terai
Study Design: Retrospective multicenter cohort study.Purpose: This study aimed to evaluate the incidence of cage subsidence and its impact on the clinical outcomes of anterior–posterior spinal fixation (APSF) for osteoporotic vertebral fractures (OVFs). It also aimed to identify the risk factors for cage subsidence.Overview of Literature: The risk factors for cage subsidence after APSF for OVFs remain unclear.Methods: This multicenter retrospective cohort study included patients who underwent combined APSF using an expandable cage system, with a minimum 1-year follow-up at multiple centers. Patients were divided into cage subsidence (n=53) and non-subsidence (n=47) groups. Demographic data, surgery-related factors, and radiographic parameters were analyzed. After univariate analysis of factors associated with cage subsidence, multivariate logistic regression was used to identify related factors.Results: The demographic data showed a significant difference in Hounsfield unit (HU) (102.6±28.3 vs. 80.0±30.6, p=0.005) and endplate injury (p<0.001). Furthermore, 1A1B fixation was significantly more common in the subsidence group (p<0.001). Radiographic data showed significant differences in Δlocal kyphosis (supine-standing) (−7.1°±9.2° vs. −14.6°±11.5°, p=0.001). Multivariate analysis showed that Δlocal kyphosis (supine-standing) (adjusted odds ratio [aOR], 12.8; p=0.010), HU (aOR, 8.1; p=0.033), fixation range (aOR, 8.2; p=0.020), and endplate injury (aOR, 18.8; p=0.011) were significant risk factors for subsidence.Conclusions: Intraoperative endplate injury, low HU (<87.5), short fusion, and preoperative vertebral instability (Δlocal kyphosis [supinestanding] <−14) were identified as risk factors for cage subsidence in APSF. Therefore, extending the fusion levels in patients with low HU values and significant preoperative vertebral instability should be considered to avoid intraoperative endplate injury.

6 September 2025 in Global Spine Journal
Verified
Journal Article
Open access
MUMasato Uematsu
Masato Uematsu
KTKoji Tamai
Koji Tamai
MKMinori Kato
Minori Kato
HTHiromitsu Toyoda
Hiromitsu Toyoda
ASAkinobu Suzuki
Akinobu Suzuki
HTHidetomi Terai
Hidetomi Terai
Study Design: Retrospective cohort study. Objective: Condoliase is a chemonucleolysis for lumbar disc herniation (LDH) that enzymatically degrades herniated disc material with high specificity for chondroitin sulfate and hyaluronic acid. Few studies have compared condoliase treatment with surgical treatments. We compared the clinical outcomes of condoliase treatment and minimally invasive discectomy. Methods: Patients who received condoliase treatment or minimally invasive discectomy at single institution were included. Propensity score matching was performed to adjust for age and sex. We included 146 patients with LDH (73 per group). The Japan Orthopaedic Association (JOA) score, visual analog scale (VAS) for leg pain, and disc height and degeneration were assessed at baseline and 2 weeks, 3 months, and 1 year after treatment. Results: The JOA score and leg pain VAS improved significantly over time ( P < .001, Friedman’s test). Two weeks after treatment, a marked improvement in JOA score and leg pain VAS was observed in the surgery group compared with the condoliase group ( P < .001, mixed-effects model). However, 3 months and 1 year after treatment, the differences were not significant. In contrast, disc height reduction was significantly greater in the condoliase group than in the surgery group at 3 months and 1 year after treatment ( P < .001, mixed-effects model). Condoliase treatment was identified as an independent risk factor for progression of disc degeneration (odds ratio, 23.60; P = .001, logistic regression analysis). Conclusion: Condoliase treatment demonstrated mid-term efficacy comparable to surgical treatment; however, it required more time for pain relief and was potentially associated with progression of disc degeneration.